Compliance Certificate in accordance with regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended March 31, 2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Aspira Pathlab & Diagnostics has submitted a routine compliance certificate to BSE for the quarter ended March 31, 2025. The certificate was issued by the company's Registrar and Share Transfer Agent, MUFG Intime India Private Limited (formerly Link Intime India). It confirms that all physical share certificates received from depository participants for dematerialization during the quarter were properly processed, confirmed, or rejected by the depositories. The certificates were mutilated and cancelled, and the depository's name has been substituted as the registered owner in the company's register of members within the required timelines. This is a standard quarterly regulatory filing with no business or financial details disclosed.
No material impact on shareholders or the stock. This is a routine procedural filing required by SEBI and does not affect the company's operations, financials, or shareholding structure in any meaningful way.